LifeStance Health Group (NASDAQ:LFST) Price Target Cut to $8.00 by Analysts at The Goldman Sachs Group
LifeStance Health Group (NASDAQ:LFST – Free Report) had its price target decreased by The Goldman Sachs Group from $9.00 to $8.00 in a research note issued to investors on Wednesday, Benzinga reports. The Goldman Sachs Group currently has a neutral rating on the stock. Separately, JPMorgan Chase & Co. lowered their price target on shares […]